107 related articles for article (PubMed ID: 19391415)
1. [Therapy of gastric acid-induced illnesses in general practice. The first pantoprazole generic drug has arrived].
MMW Fortschr Med; 2009 Jan; 151(5):46-7. PubMed ID: 19391415
[No Abstract] [Full Text] [Related]
2. [Analysis of actual costs in long-term therapy of reflux disease. Use of pantoprazole counts].
MMW Fortschr Med; 2008 Oct; 150(40):52-3. PubMed ID: 18990887
[No Abstract] [Full Text] [Related]
3. [Decreased need for tablets with pantoprazole. PPI: independent study questions savings through use of generic drugs].
MMW Fortschr Med; 2007 Dec; 149(49-50):58. PubMed ID: 18236985
[No Abstract] [Full Text] [Related]
4. A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in The Netherlands.
van Hout BA; Klok RM; Brouwers JR; Postma MJ
Clin Ther; 2003 Feb; 25(2):635-46. PubMed ID: 12749518
[TBL] [Abstract][Full Text] [Related]
5. [General practitioners' management of gastroesophageal reflux in France in 2005: a pharmacoeconomic study].
Mouly S; Charlemagne A; Le Jeunne P; Fagnani F
Presse Med; 2008 Oct; 37(10):1397-406. PubMed ID: 18502602
[TBL] [Abstract][Full Text] [Related]
6. Generics offer pharmacy plans specific benefits.
Reinke T
Manag Care; 2010 Feb; 19(2):28-30, 34. PubMed ID: 20550049
[No Abstract] [Full Text] [Related]
7. [Gastroesophageal reflux in the adult: medical-economic aspects of therapeutic strategies].
Lebrun T; Bouchez M; Allenet B
Gastroenterol Clin Biol; 1999 Jan; 23(1 Pt 2):S165-75. PubMed ID: 10078445
[No Abstract] [Full Text] [Related]
8. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
Lucas LM; Gerrity MS; Anderson T
Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
[TBL] [Abstract][Full Text] [Related]
9. The acid test for formulary policy.
McCaffrey E
Bus Health; 1999 Dec; 17(12 Suppl A):19-24. PubMed ID: 10747676
[No Abstract] [Full Text] [Related]
10. [Preparation sanpraz (pantoprazole): experience of application in treatment of gastroesophageal reflux disease and other acid related diseases].
Sharova EP
Eksp Klin Gastroenterol; 2008; (6):74-6. PubMed ID: 19334429
[No Abstract] [Full Text] [Related]
11. The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--pharmacoeconomics and its application to antisecretory drugs: a case study.
Morreale A
Manag Care Interface; 2001; Suppl B():28-30; discussion 31-3. PubMed ID: 11569296
[No Abstract] [Full Text] [Related]
12. [Efficacy and tolerability of pantoprazole in the treatment of gastroesophageal reflux disease].
Gillessen A
MMW Fortschr Med; 2010 May; 152(18):52. PubMed ID: 20514766
[No Abstract] [Full Text] [Related]
13. [Drug treatment and surgical indications in gastroesophageal reflux].
PĂ©rez-Manauta J
Rev Gastroenterol Mex; 2007 Nov; 72 Suppl 2():13-6. PubMed ID: 18277473
[No Abstract] [Full Text] [Related]
14. OTC omeprazole for your heartburn--enormous value-for-money opportunity.
Curtiss FR
J Manag Care Pharm; 2004; 10(5):458-60. PubMed ID: 15369431
[No Abstract] [Full Text] [Related]
15. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.
Miner P; Katz PO; Chen Y; Sostek M
Am J Gastroenterol; 2003 Dec; 98(12):2616-20. PubMed ID: 14687806
[TBL] [Abstract][Full Text] [Related]
16. Acid pump inhibitors. The treatment of gastroesophageal reflux.
Hetzel D
Aust Fam Physician; 1998 Jun; 27(6):487-91. PubMed ID: 9648315
[TBL] [Abstract][Full Text] [Related]
17. Review article: efficacy and safety of rabeprazole in treating gastroesophageal reflux disease.
Lim PW; Goh KL
J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S61-8. PubMed ID: 15324384
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of immediate-release omeprazole oral suspension, delayed-release lansoprazole capsules and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptoms.
Katz PO; Koch FK; Ballard ED; Bagin RG; Gautille TC; Checani GC; Hogan DL; Pratha VS
Aliment Pharmacol Ther; 2007 Jan; 25(2):197-205. PubMed ID: 17229243
[TBL] [Abstract][Full Text] [Related]
19. Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients.
Calabrese C; Liguori G; Gabusi V; Gionchetti P; Rizzello F; Straforini G; Brugnera R; Di Febo G
Aliment Pharmacol Ther; 2008 Jul; 28(2):250-5. PubMed ID: 18485128
[TBL] [Abstract][Full Text] [Related]
20. [Cost-effectiveness analysis for the treatment of non-erosive reflux disease].
Habu Y; Fukui Y; Maruno T; Hisatsune H; Kawai K
Nihon Rinsho; 2007 May; 65(5):951-5. PubMed ID: 17511239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]